Ibutilide Fumarate Injection Articles
P&U's Corvert improves AF treatment
24 June 1999
Record Number Of New Chemical Entities In 1996
20 January 1997
P&U To Combine Businesses
23 December 1996
P&U Launches First Atrial Fibrillation Drug In the USA
22 April 1996
Pharmacia & Upjohn First Combined Results
26 February 1996
FDA Year-End Approvals Round-Up
8 January 1996
Corvert Effective For Arrhythmia, Says Panel
30 October 1995
Showing 1-7 of 7 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
